Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 4141 AL 4155

A Meta-Analysis of fMRI Activation Differences during Episodic Memory in Alzheimer's Disease and Mild Cognitive Impairment

Terry DP, Sabatinelli D, Puente AN, Lazar NA, Miller LS.

J Neuroimaging. 2015 Nov-Dec;25(6):849-60. doi: 10.1111/jon.12266. Epub 2015 Jun 16.

Naming ability in patients with mild to moderate Alzheimer's disease: what changes occur with the evolution of the disease?

Silagi ML, Bertolucci PH, Ortiz KZ.

Clinics (Sao Paulo). 2015 Jun;70(6):423-8. doi: 10.6061/clinics/2015(06)07. Epub 2015 Jun 1.

Advancements in the treatment of agitation in Alzheimer's disease

Antonsdottir IM, Smith J, Keltz M, Porsteinsson AP.

Expert Opin Pharmacother. 2015;16(11):1649-56. doi: 10.1517/14656566.2015.1059422.

Assessment of Functional Characteristics of Amnestic Mild Cognitive Impairment and Alzheimer's Disease Using Various Methods of Resting-State FMRI Analysis

Cha J, Hwang JM, Jo HJ, Seo SW, Na DL, Lee JM.

Biomed Res Int. 2015;2015:907464. doi: 10.1155/2015/907464. Epub 2015 Jun 9.

The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding

Beckett LA, Donohue MC, Wang C, Aisen P, Harvey DJ, Saito N; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):823-31. doi: 10.1016/j.jalz.2015.05.004.

Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy

Barban F, Annicchiarico R, Pantelopoulos S, Federici A, Perri R, Fadda L, Carlesimo GA, Ricci C, Giuli S, Scalici F, Turchetta CS, Adriano F, Lombardi MG, Zaccarelli C, Cirillo G, Passuti S, Mattarelli P, Lymperopoulou O, Sakka P, Ntanasi E, Moliner R, Garcia-Palacios A, Caltagirone C.

Int J Geriatr Psychiatry. 2016 Apr;31(4):340-8. doi: 10.1002/gps.4328. Epub 2015 Jul 23.

Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease

Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG; CitAD Research Group.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1127-33. doi: 10.1016/j.jagp.2015.05.006. Epub 2015 May 19.

Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia

Sacuiu S, Insel PS, Mueller S, Tosun D, Mattsson N, Jack CR Jr, DeCarli C, Petersen R, Aisen PS, Weiner MW, Mackin RS; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2016 Feb;24(2):126-35. doi: 10.1016/j.jagp.2015.03.006. Epub 2015 Mar 30.

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A.

Nat Rev Neurosci. 2015 Sep;16(9):564-74. doi: 10.1038/nrn3983. Epub 2015 Aug 5.

Mini-Mental State Examination for the Detection of Alzheimer Disease and Other Dementias in People With Mild Cognitive Impairment

Skorga P, Young CF.

Clin Nurse Spec. 2015 Sep-Oct;29(5):265-7. doi: 10.1097/NUR.0000000000000150.

EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW

de Souza Fernandes DP, Canaan Rezende FA, Pereira Rocha G, De Santis Filgueiras M, Silva Moreira PR, Gonçalves Alfenas Rde C.

Nutr Hosp. 2015 Aug 1;32(2):528-33. doi: 10.3305/nh.2015.32.2.9111.

Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences

Peters ME, Vaidya V, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Avramopoulos D; CitAD Research Group.

J Geriatr Psychiatry Neurol. 2016 Mar;29(2):59-64. doi: 10.1177/0891988715601735. Epub 2015 Aug 23.

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG; CitAD Research Group.

Int Psychogeriatr. 2015 Dec;27(12):2059-67. doi: 10.1017/S1041610215001106. Epub 2015 Aug 25.

Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies

Tromp D, Dufour A, Lithfous S, Pebayle T, Després O.

Ageing Res Rev. 2015 Nov;24(Pt B):232-62. doi: 10.1016/j.arr.2015.08.006. Epub 2015 Aug 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias